• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Human Normal Immunoglobulin
    10 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Filter by letter: ALL A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
    Beriglobin P
    Genmedix
    RX
    partial basket chart
    Beriglobin P

    Immunoglobulins. Human Normal Immunoglobulin 160 mg/ml.
    PFS: 1 x 2 cc, 5 cc. See lit.
    Defic. defect. antibody synth., protracted
    transitory hypogammaglobulem.,
    proph. hepatit. A, measles or attenuat.
    measles.
    C/I: Severe thrombocytopen., other
    coag. disords., isolated immunoglobulin
    A (IgA) defic.

    Flebogamma 5% DIF
    Medici
    RX
    partial basket chart
    Flebogamma 5% DIF

    Human Normal Immunoglobulin 0.5 g / 10 ml.
    VIALS: 1 x 0.5 g, 2.5 g, 5 g, 10 g. See lit.
    Replacement ther. in: Prim. immunodefic.
    synds. such as: congen.
    agammaglobulinem./
    hypogammaglobulinem; common
    variable immunodefic.; severe combined
    immunodefic.; Wiscott Aldrich syndr.
    Myeloma/chron. lympocyt. leukem. with
    severe second. hypogammaglobuline.
    and recurr. infects. Child with congenital
    AIDS and recurr. infects.
    Immunomodulat: ITP in child or adults at
    high risk of bleed./prior to surgery to
    correct the platelet count. Guillain Barre
    syndr., Kawasaki dis., allogeneic bone
    marrow transplant.
    C/I: History anaphylact. or severe
    system. response to I.M./I.V.
    immunoglob. preps.

    Gammaplex
    Kamada
    RX
    partial basket chart
    Gammaplex

    Human Normal Immunoglobulin 5 g/100 ml.
    VIALS: 1 x 2.5 g/50 ml, 5 g/100 ml, 10
    g/200 ml. Dose depend. indicat. and
    pharmacokinetic/clinic. response. See lit.
    Replace. ther. in: Prim. immunodefic.
    (congen. agammaglobulinem.,
    hypogammaglobulinem., common
    variable immunodefic.); Wiskott Aldrich
    syndr. Myeloma/chron. lymphocytic leuk.
    with severe second.
    hypogammaglobulinem and recurr.
    infects. Child with congen. AIDS and
    recurr. infects.
    C/I: Hypersens. See lit.

    Gamunex C
    Perrigo
    RX
    partial basket chart
    Gamunex C

    Human Normal Immunoglobulin 0.1 gr/ml.
    VIAL: 1 x 10 ml, 25 ml, 50 ml, 100 ml.
    See lit.
    Prim. immunodefic. (PI), idiopath.
    thrombocytopen. purpura (ITP). Chron.
    inflamm. demyelinat. polyneuropath.
    (CIDP).
    C/I: Known anaphylact./severe system.
    response to human immunoglob.,
    severe select. IgA defic. See lit.

    Intratect 100 g/l
    Kamada
    RX
    not in the basket chart
    Intratect 100 g/l

    Immunoglobulins. Human Normal Immunoglobulin 100 g/l.
    VIAL (sol. for infus.): 1x10 ml, 25 ml, 50 ml, 100 ml, 200 ml. Replacement ther. in primary immunodefic., init. dose: 0.4-0.8 g/kg, thereafter 0.2-0.8 g/kg every 3-4 wks. to obtain IgG trough level of at least 5-6 g/l.
    Replacem. ther. in second. immunodefic.: 0.2-0.4 g/kg, every 3-4 wks. to obtain IgG trough level of at least 5-6 g/l.
    Congenit. AIDS: 0.2-0.4 g/kg, every 3-4 wks.

    Hypogammaglobulinaemia (<4 g/l) in pts. after allogeneic haematopoietic stem cell transplant.: 0.2-0.4 g/kg, every 3-4 wks. to obtain IgG trough level above 5 g/l
    .
    Prim. immune thrombocytop.: 0.8-1 g/kg on day 1, possibly repeated once within 3 days, or 0.4 g/kg/d for 2-5 d.
    Guillain Barré syndr.: 0.4 g/kg/d for 5 d.
    Kawasaki dis.: 1.6-2 g/kg in divided doses over 2-5 d. in assoc. with acetylsalic. acid or 2 g/kg in one dose in assoc. with acetylsalic. acid.
    Method of admin.: initial rate of not more than 1.4 ml/kg/h for 30 min.
    If well toler., the rate of admin. may gradual. be incr. to a max. of 1.9 ml/kg/h for the remainder of the infus.
    Replacement Therapy: In pts. who have tolerated the infus. rate of 1.9 ml/kg/h well, the rate may be gradual. incr.to 6 ml/kg/h and if still tolerat. well, it may be further incr. gradual. to a max. of 8 ml/kg/h.
    In general, dosage and infus. rates have to be individ. tailor. accord.to the pt's needs.
    Replacem. ther. in adult., and child. & adolesc. (0-18 yrs.) in:
    Primary immunodefic. syndr. with impair. antibod. product.
    Hypogammaglobulinaemia and recur. bact. infec. in pts. with chron. lymphocytic leukaemia, in whom prophylact. antibiotics have failed.
    Hypogammaglobulinaemia and recur. bact. infec. in plateau phase multiple myeloma pts. who have failed to respond to pneumococcal immunisat.
    Hypogammaglobulinaemia in pts. after allogen. haematop. stem cell transplant. (HSCT).
    Congen. AIDS with recur. bact. infec.
    Immunomodulat. in adul., and child. and adolesc. (0-18 yrs.) in:
    Prim. immune thrombocytop. (ITP), in pts. at high risk of bleed. or prior to surg. to correct the platelet count.
    Guillain Barré syndr.
    Kawasaki dis.
    C/I: Hypersens. Pts. with selective IgA defic. who develop. antibod. to IgA, as admin. an IgA-contain. product can result in anaphylax.

    Intratect 50 g/l
    Kamada
    RX
    partial basket chart
    Intratect 50 g/l

    Immunoglobulins. Human Normal Immunoglobulin 50 mg/ml.
    VIAL (sol.for infus.): 20, 50, 100, 200 ml. Method of admin. for all indic. Should be infus. IV at an init. rate of not more than 1.4 ml/kg/h for 30 min. If well tolerated. the rate of admin. may gradually be incr. to a max. of 1.9 ml/kg/h for the remainder of the infus.
    Replacement ther. in primary immunodefic., init. dose: 0.4-0.8 g/kg, thereafter 0.2-0.8 g/kg every 3-4 wks. to obtain IgG trough level of at least 5-6 g/l.
    Replacem. ther. in second. immunodefic.: 0.2-0.4 g/kg, every 3-4 wks. to obtain IgG trough level of at least 5-6 g/l. Congenit. AIDS: 0.2-0.4 g/kg, every 3-4 wks.
    Hypogammaglobulinaemia (< 4 g/l) in pts. after allogeneic haematopoietic stem cell transplant.: 0.2-0.4 g/kg, every 3-4 wks. to obtain IgG trough level above 5 g/l
    .
    Prim. immune thrombocytop.: 0.8-1 g/kg on day 1, possibly repeated once within 3 days, or 0.4 g/kg/d for 2-5 d.
    Guillain Barré syndr.: 0.4 g/kg/d for 5 d.
    Kawasaki dis.: 1.6-2 g/kg in divided doses over 2-5 d. in assoc. with acetylsalic. acid or 2 g/kg in one dose in assoc. with acetylsalic. acid
    .
    Replacem. ther. in adult., and child. & adolesc. (0-18 yrs.) in:
    Primary immunodefic. syndr. with impair. antibod. product.
    Hypogammaglobulinaemia and recur. bact. infec. in pts. with chron. lymphocytic leukaemia, in whom prophylact. antibiotics have failed.
    Hypogammaglobulinaemia and recur. bact. infec. in plateau phase multiple myeloma pts. who have failed to respond to pneumococcal immunisat.
    Hypogammaglobulinaemia in pts. after allogen. haematop. stem cell transplant. (HSCT).
    Congen. AIDS with recur. bact. infec.
    Immunomodulat. in adult., and child. and adolesc.(0-18 yrs.) in:
    Prim. immune thrombocytop. (ITP), in pts. at high risk of bleed. or prior to surg. to correct the platelet count.
    Guillain Barré syndr.
    Kawasaki dis.
    C/I: Hypersens. Pts. with selective IgA defic. who develop. antibod. to IgA, as admin. an IgA-contain. product can result in anaphylax.

    CLOSE